Last reviewed · How we verify

NCT06126289

CSF Single-cell Sequencing and Proteomics of Chronic Postsurgical Pain in Patients With Lower Limb Fractures

Status unknown Last updated 13 November 2023
What this trial tests

trial in Chronic Postsurgical Pain in 20 participants. Status unknown.

Timeline
25 December 2023
Primary endpoint
30 July 2025
30 July 2025

Quick facts

Lead sponsorXuzhou Central Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment20
Start date25 December 2023
Primary completion30 July 2025
Estimated completion30 July 2025

Conditions studied

Sponsor

Xuzhou Central Hospital

Who can join

Eligibility, any sex, with Chronic Postsurgical Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the proteomics and transcriptomic differences between pain-free control subjects and patients with chronic postoperative pain through single-cell sequencing technology.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Postsurgical Pain

Currently open trials in the same condition.

Other Xuzhou Central Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06126289.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing